Axsome Therapeutics, Inc. (0HKF.L) LSE

125.11

+1.71(+1.39%)

Updated at September 08 05:59PM

Currency In USD

Valuation

Market Cap4.05B
Enterprise Value3.93B
P/E Ratio-25.89
PEG Ratio-2.13
Price/Sales Ratio13.03
Price/Book Ratio87.48
Enterprise/Revenue12.86
Enterprise/EBITDA-28.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.5
Operating Margin-0.46

Management Effectiveness

Return On Assets-0.39
Return On Equity-3.58

Income Statement

Revenue385.69M
Revenue/Share10.01
Gross Profit352.39M
EBITDA-272.6M
Net Income-287.22M
Diluted EPS-5.99

Balance Sheet

Total Cash303.02M
Total Cash/Share6.13
Total Debt215.29M
Total Debt/Equity2.95
Current Ratio1.57
Book Value Per Share1.48

Price History

52-Week Change32.1
52-Week High127.4
52-Week Low55.64
Moving Average 50 Days85.35
Moving Average 200 Days75.3

Statistics

Average Volume562
Shares Outstanding48.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A